Orris

patient having bp 160/90 in morning and was admistered with lasix 2ml and Labetalol 2ml and at evening there was no reduction bp was 170/90 and was again admistered with Labetalol 2ml patient is also diabetic

Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

"hypertension"[MeSH Terms] AND "diabetes mellitus"[MeSH Terms] AND "blood pressure"

Reading File
Reading File
Short answer: 160/90 and 170/90 are not emergencies. They need a proper review and a scheduled regimen, not repeated IV doses of labetalol. I don't know the setting, so this is general guidance for the treating team.
Why the BP didn't fall
  • Furosemide and labetalol given as one-off doses work briefly. Labetalol IV lasts only a few hours, so a BP of 170/90 by evening is expected if no maintenance antihypertensive was started.
  • Check the doses in mg. Labetalol injection is usually 5 mg/mL, so 2 mL is about 10 mg. Furosemide is usually 10 mg/mL, so 2 mL is about 20 mg. These are low, so a poor response is not surprising.
  • Furosemide only helps if the patient is volume overloaded.
Is this urgent?
  • A hypertensive emergency means a high BP plus acute target organ damage. Examples are encephalopathy, stroke, ACS, pulmonary edema, aortic dissection, AKI and retinal hemorrhage or papilledema. - Brenner and Rector's The Kidney, p. 2069.
  • Patients with very high BP but no acute organ damage were traditionally called "hypertensive urgency." Studies in over 1,000 ED patients and over 58,000 outpatients found very low morbidity and no prognostic benefit from acute treatment compared with prompt follow-up. - Brenner and Rector's The Kidney, p. 2069.
  • Headache, epistaxis and dizziness alone do not mean organ damage and do not call for acute BP lowering. - Rosen's Emergency Medicine, Ch. 70.
  • This patient's readings are below 180/120, so they are not in the urgency range.
What I would do
  1. Look for organ damage. Check symptoms (chest pain, dyspnea, neurologic deficit, confusion, visual change), fundi, ECG, urine dipstick, creatinine and electrolytes.
  2. Look for reversible causes. These include pain, anxiety, a full bladder, missed home antihypertensives, NSAIDs or steroids, high salt or fluid load, and hyperglycemia or infection. Confirm the cuff size and technique, and repeat the reading.
  3. Rule out pregnancy or postpartum status. If she is pregnant or postpartum, a systolic BP of 160 or more is in the severe range and needs urgent treatment per obstetric protocol. Labetalol, nifedipine and methyldopa are the usual first-line drugs there. - Creasy & Resnik's Maternal-Fetal Medicine.
  4. Start a maintenance regimen instead of PRN IV doses. Aim for gradual control. Even in true emergencies, BP is lowered about 25% over the first few hours, not normalized quickly. - Brenner and Rector's The Kidney, p. 2069.
  5. Choose drugs with diabetes in mind. Preferred classes in diabetes are an ACE inhibitor or ARB, with a calcium-channel blocker or thiazide-type diuretic added. - Goldman-Cecil Medicine, Table 64-9. Check creatinine and potassium before starting an ACEi or ARB.
  6. Do not use PRN doses as the main plan. Repeated IV labetalol can cause bradycardia, hypotension and, in diabetics, a masked or prolonged hypoglycemia. Beta blockers can blunt the warning signs of hypoglycemia except sweating. - Goodman & Gilman's, Blockade of β Adrenergic Receptors. Monitor glucose closely.
Cautions with labetalol
  • Avoid it in asthma or COPD with bronchospasm, in significant bradycardia or heart block, and in decompensated heart failure.
  • Check the pulse and BP before each dose, and keep the patient supine or monitored after an IV dose.
Escalate to a physician now if the BP is 180/110 or higher on repeat, or there are neurologic symptoms, chest pain, dyspnea, vomiting, visual change or falling urine output.
Recent evidence: I found a 2026 Cochrane review on BP targets in diabetes and a 2026 JACC dose-response meta-analysis. I did not read them in full. They concern long-term targets, not acute management. Most guidelines still aim for about 130/80 over the long term in diabetes. Confirm the target against your local protocol.
If you tell me the patient's age, whether she is pregnant or postpartum, her kidney function, her usual medications and any symptoms, I can tailor this further.

Which oral antihypertensives are best for a diabetic with high BP?

Reading File
Finding Sources
Reading File
Searching PubMed

"hypertension"[MeSH Terms] AND "diabetes mellitus"[MeSH Terms] AND "antihypertensive agents"[MeSH Terms]

First-line oral drugs for hypertension in a diabetic
Start with an ACE inhibitor or an ARB. Add a calcium-channel blocker or a thiazide-type diuretic as needed.
  • About 80% of patients with type 2 diabetes have hypertension. No compelling evidence favors one first-line drug, but treatment usually begins with an ACE inhibitor or ARB plus a calcium-channel blocker, or perhaps a thiazide-like diuretic. - Goldman-Cecil Medicine, Diabetes and Normal Renal Function.
  • The Goldman-Cecil table of preferred classes (Table 64-9, p. 753) lists the same for diabetes: ACE inhibitor or ARB, with a calcium-channel blocker or diuretic. For diabetes with nephropathy (urine albumin:creatinine over 300 mg/g), the ACEi or ARB is combined with a calcium-channel blocker or diuretic.
How to choose by situation
SituationPreferred choice
Hypertension with albuminuria or kidney diseaseACE inhibitor or ARB. This is the first choice because it slows kidney disease progression.
Type 1 diabetes with hypertension and albuminuriaACE inhibitor
Type 2 diabetes with microalbuminuriaACE inhibitor or ARB
Type 2 diabetes with overt diabetic kidney diseaseARB as first-line, per Brenner and Rector's The Kidney, Renin-Angiotensin-Aldosterone section. If it is not tolerated, substitute the other class.
Hypertension, normal urine albuminACE inhibitor or ARB, or a calcium-channel blocker
Not controlled on one drugAdd a second class from the group above (ACEi or ARB with amlodipine or a thiazide-like diuretic such as chlorthalidone or indapamide). Most patients need 2 or more drugs.
Practical points
  • Do not combine an ACE inhibitor with an ARB. Dual blockade has been linked to worse outcomes, especially hyperkalemia and AKI. - National Kidney Foundation Primer on Kidney Diseases.
  • Check creatinine and potassium before starting and again in 1 to 2 weeks. A creatinine rise of up to about 30% is acceptable. Avoid ACEi and ARBs in pregnancy, bilateral renal artery stenosis and hyperkalemia.
  • Thiazide-like diuretics can raise glucose slightly and lower potassium. Low doses are fine and add real benefit, and they work well with an ACEi or ARB. Monitor sodium and potassium.
  • Amlodipine is metabolically neutral. Its common side effect is ankle edema, which is less of a problem when combined with an ACEi or ARB.
  • Beta blockers are not first-line unless there is a separate indication, such as coronary disease, heart failure, post-MI or arrhythmia. They can mask hypoglycemia, and older agents may worsen glucose control. Carvedilol is metabolically favorable in diabetes. - Goodman & Gilman's, Carvedilol.
  • Spironolactone is the usual fourth drug for resistant hypertension. Monitor potassium closely, especially with an ACEi or ARB.
  • Long-term BP target: most guidelines aim for below about 130/80 if tolerated. Confirm against your local guideline.
Recent evidence: A 2025 meta-analysis stratified by albuminuria looked at RAS inhibitors, calcium-channel blockers and diuretics in hypertensive diabetics (PMID 39953235). I only saw its title, not the findings, so I can't say whether it changes the above. The textbook position is still the standard.
For the patient you described, the earlier caveats still apply. Check kidney function and urine albumin first, since they decide whether an ACEi or ARB is a must. Rule out pregnancy, because ACEi and ARBs are contraindicated there.

How to manage resistant hypertension in a diabetic patient?

Reading File
Reading File
Reading File
Finding Sources
Searching PubMed

"resistant hypertension" AND "diabetes mellitus"[MeSH Terms]

Resistant hypertension in a diabetic: management
1. Confirm it is truly resistant
  • Definition: BP stays above target despite three guideline-recommended drugs at optimal or maximum tolerated doses. These are usually a RAS blocker, a calcium-channel blocker and a thiazide or thiazide-like diuretic. US guidance also counts patients who are controlled only on four drugs. - Comprehensive Clinical Nephrology, Resistant Hypertension.
  • Rule out pseudoresistance first. Up to 9 in 10 patients first labeled resistant are excluded after this screen. The usual reasons are suboptimal therapy, white-coat effect and non-adherence. - Comprehensive Clinical Nephrology.
    • Check the cuff size, since a cuff that is too small overestimates BP.
    • Confirm with home BP or 24-hour ambulatory monitoring (ABPM).
    • Check adherence.
  • White-coat effect drives much of the apparent prevalence. In the SYMPLICITY HTN-3 renal denervation trial, more than 60% of screened patients failed screening because of white-coat hypertension. - Brenner and Rector's The Kidney, Resistant Hypertension.
  • Diabetes, CKD, obesity, older age and Black race all raise the risk of true resistant hypertension and of cardiovascular events. - Brenner and Rector's The Kidney.
2. Remove contributors
  • Drugs that raise BP: NSAIDs, decongestants, steroids, oral contraceptives, some antidepressants, stimulants, and alcohol.
  • Lifestyle and volume: high salt intake, obesity and obstructive sleep apnea.
  • Poor glycemic control: hyperglycemia causes osmotic diuresis and volume shifts, and drives kidney damage.
  • Resistant hypertension is usually non-adherence plus volume overload from poor kidney function and a high-sodium diet. - Brenner and Rector's The Kidney.
3. Screen for secondary causes
  • Primary aldosteronism is common in resistant hypertension. Check an aldosterone:renin ratio and potassium.
  • Renal artery stenosis: suspect it if there is a creatinine rise on an ACEi or ARB, flash pulmonary edema, or an abdominal bruit.
  • CKD and diabetic kidney disease: check eGFR and urine albumin:creatinine.
  • Others: sleep apnea, thyroid disease, pheochromocytoma (rare), Cushing syndrome.
4. Optimize the three-drug base
  • ACEi or ARB at the maximum tolerated dose. This is essential in diabetes with albuminuria. Do not combine the two. - National Kidney Foundation Primer.
  • Amlodipine (or diltiazem, which gives an added antiproteinuric effect in very high albuminuria). - Brenner and Rector's The Kidney, Fig. 46.17.
  • Switch to a long-acting thiazide-like diuretic (chlorthalidone or indapamide). In advanced CKD (eGFR below about 30), use a loop diuretic instead, given once or twice daily.
  • PATHWAY-2 showed resistant hypertension is most often a sodium-retaining state. Diuretic optimization is therefore the main step. - Comprehensive Clinical Nephrology.
5. Add the fourth drug
  • Spironolactone 12.5 to 25 mg daily (eplerenone if gynecomastia is a problem) is the preferred fourth drug. After a calcium antagonist, a diuretic and a RAAS blocker, mineralocorticoid antagonists have shown significant benefit. - Brenner and Rector's The Kidney.
  • Monitor potassium and creatinine closely at 1 and 4 weeks, then periodically. Hyperkalemia is the main risk in diabetics on an ACEi or ARB, especially with CKD, because they are prone to type 4 renal tubular acidosis. Avoid it if potassium is above about 5.0 or eGFR is below about 30, or do so only with specialist input.
  • Finerenone is a non-steroidal mineralocorticoid antagonist. It cut kidney and cardiovascular events in type 2 diabetes with CKD (FIDELIO-DKD and FIGARO-DKD), as cited in Katzung's Basic and Clinical Pharmacology. It is mainly a kidney and cardiac protective choice. It is not established as the standard fourth-line BP drug in resistant hypertension.
6. If still uncontrolled
  • Add a beta blocker (carvedilol or bisoprolol) if there is a compelling indication. Otherwise add doxazosin or hydralazine, or clonidine (watch for rebound if doses are missed).
  • Avoid combining a beta blocker and non-dihydropyridine calcium blocker without monitoring the heart rate.
  • Refer to a hypertension or nephrology specialist. Renal denervation is a possibility, but trial results have been mixed. The 2023 and 2024 meta-analyses (PMID 37150718, PMID 37890022) cover sham-controlled trials and treatment comparisons, but I only saw their titles, not the results.
Diabetes-specific points
  • Glucose monitoring: beta blockers can mask hypoglycemia. Thiazide-like diuretics may raise glucose a little.
  • Orthostatic hypotension and autonomic neuropathy: check standing BP. Diabetic autonomic neuropathy can cause supine hypertension with postural drops.
  • Target: about 130/80 if tolerated. Do not lower BP too aggressively in patients with orthostatic hypotension. Follow your local guideline.
  • Kidney protection: SGLT2 inhibitors modestly lower BP and protect the kidneys and heart in type 2 diabetes with CKD or heart failure. Discuss them with the diabetes team.
Applying this to your patient: the clinic readings of 160/90 and 170/90 were treated with one-off IV doses. First, put the patient on a regular oral regimen (ACEi or ARB, plus amlodipine, plus a thiazide-like diuretic). Reassess after 4 weeks of confirmed adherence and monitoring before calling it resistant.
Recent literature note: a 2026 meta-analysis on the prevalence of resistant hypertension in type 2 diabetes exists (PMID 42300314). I only saw the title, so I can't comment on its figures.

so this is chronic hypertension of which stage

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Stage 2 hypertension by the ACC/AHA classification, which is the current US system.
CategorySystolic (mm Hg)Diastolic (mm Hg)
Normal<120and<80
Elevated120-129and<80
Stage 1130-139or80-89
Stage 2≥140or≥90
  • National Kidney Foundation Primer on Kidney Diseases, Classification of Blood Pressure Status (adapted from Whelton et al., ACC/AHA 2017)
How your patient fits
  • 160/90 and 170/90 both fall in stage 2, because the systolic is 140 or higher and the diastolic is 90.
  • When systolic and diastolic fall in different categories, the higher one is used. - Harrison's Principles of Internal Medicine, 22nd ed., Definition of Hypertension.
  • A formal diagnosis needs the average of two or more readings on two or more occasions, with correct technique. - Harrison's, 22nd ed. Two clinic readings, one in the morning and one in the evening, are a good start but are not a confirmed diagnosis.
"Chronic" hypertension
  • Stage describes severity. "Chronic" describes duration and type, meaning long-standing or pre-existing primary hypertension.
  • I can't tell from what you've given whether this is chronic. It is only chronic if the patient has a known history of hypertension or has been on antihypertensives. If this is the first time it has been found, it is newly diagnosed stage 2 hypertension. A pregnancy-related cause or an acute illness would also change the label.
  • "Chronic hypertension" is also a specific diagnosis in pregnancy, meaning hypertension present before pregnancy or before 20 weeks. If your patient is pregnant, tell me, because the thresholds and drugs are different. - Fuster and Hurst's The Heart, Hypertensive Diseases of Pregnancy.
Other points on classification
  • Some guidelines (ESC/ESH, and many Indian and UK practices) use different grades. By the ESC/ESH system, 160/90 is grade 2 (160-179 / 100-109), and 170/90 is also grade 2 on the systolic. The label depends on which guideline your unit follows.
  • Neither reading is severe or a hypertensive crisis, which starts at 180/120.
  • Staging should also include cardiovascular risk and target organ damage. In diabetes, check for kidney disease (urine albumin:creatinine ratio, eGFR), retinopathy, left ventricular hypertrophy and neuropathy. A diabetic with stage 2 hypertension is in a high-risk group and usually needs two-drug combination therapy from the start (an ACEi or ARB plus a calcium-channel blocker or thiazide-like diuretic).
Resistant hypertension is only a label if she is adherent and still uncontrolled on three drugs at full doses. From what you've told me, this has not been tested yet.
Please confirm the patient's age, any prior hypertension diagnosis, medications and whether she is pregnant. With those I can say whether this is chronic, new or something else, and tailor the plan.

he is having uncontrolled asyptomatic stage 2 hypertension

Reading File
Finding Sources
Finding Sources
Finding Sources
An asymptomatic patient with stage 2 hypertension and no organ damage needs oral therapy started or intensified and close follow-up. He does not need IV drugs or rapid BP lowering.
Why no IV drugs
  • Acute treatment of asymptomatic severe hypertension does not prevent or reduce short-term morbidity or mortality. Uncontrolled BP does raise long-term cardiovascular and kidney risk, so it still needs treatment. - Tintinalli's Emergency Medicine, Treatment of Asymptomatic Severe Hypertension.
  • Severe asymptomatic hypertension without acute organ damage is not a hypertensive emergency. Oral therapy is appropriate, and there is no proven benefit from rapid reduction. - The Washington Manual of Medical Therapeutics, Classification.
  • Normal BP can be reached gradually over several days. Rapid drops risk cerebral hypoperfusion or coronary insufficiency. - The Washington Manual.
  • Very high BP without symptoms (usually 180/100 or higher) should be treated by starting or intensifying oral drugs as an outpatient. IV drugs in an ED or ICU are for emergencies with acute organ damage. - Harrison's, 22nd ed., Hypertensive Urgencies and Emergencies.
  • His readings of 160/90 and 170/90 are below that range. The earlier IV labetalol and furosemide doses were not needed, and repeating them is not recommended.
Plan
  1. Confirm with accurate readings. Use a correct cuff size, take repeated seated readings, and arrange home BP or 24-hour ambulatory monitoring. This excludes white-coat effect.
  2. Screen for organ damage and secondary causes (one set of tests, not repeated):
    • Examination: fundi, cardiac and neurologic exam.
    • Tests: ECG, urine dipstick and albumin:creatinine ratio, creatinine and eGFR, potassium, glucose and HbA1c, lipids.
    • Consider an aldosterone:renin ratio if hypokalemia is present or hypertension is hard to control.
  3. Start a two-drug combination, preferably as a single pill.
    • Initiate two drugs, separately or as a fixed-dose combination, in adults with stage 2 hypertension and BP more than 20/10 mm Hg above target. - Comprehensive Clinical Nephrology, 7th ed., Table 37.9 (ACC/AHA, class I).
    • Single-pill combinations improve adherence. - Fuster and Hurst's The Heart, Antihypertensive Drug Therapy.
    • A diuretic or calcium-channel blocker with an ACEi or ARB is an effective pair. Using an ACEi and an ARB together is not recommended. - Fuster and Hurst's The Heart.
    • For a diabetic, a reasonable start is an ACEi or ARB plus amlodipine. A thiazide-like diuretic is an alternative to the calcium blocker. Preferred classes in diabetes are listed in Goldman-Cecil Medicine, Table 64-9.
    • Check creatinine and potassium 1 to 2 weeks after starting an ACEi or ARB.
  4. Titrate over weeks. Reassess in about 1 month. Increase doses, then move to three drugs (ACEi or ARB, calcium blocker, thiazide-like diuretic) if the target is not met. Only call it resistant hypertension if he is adherent on three drugs at optimal doses and still uncontrolled. Spironolactone is the usual fourth drug (see my earlier answer).
  5. Address lifestyle and contributors.
    • Reduce salt, lose weight if overweight, exercise, and limit alcohol.
    • Review NSAIDs, decongestants, steroids and other drugs that raise BP.
    • Screen for sleep apnea.
    • Improve glycemic control and discuss an SGLT2 inhibitor if he has type 2 diabetes with CKD or heart failure.
  6. Target: about 130/80 for a diabetic. Lower it gradually and check for orthostatic hypotension, which is common in diabetic autonomic neuropathy.
When to escalate Send him for emergency evaluation if BP reaches about 180/120 or higher and he has chest pain, dyspnea, a neurologic deficit, confusion, visual change, severe headache, or falling urine output. Without symptoms, a very high BP of 180/110 or more can be treated with oral drugs over hours to days. Follow-up within days is important because patients who aren't followed up often don't get BP management afterward. - Tintinalli's.
Documentation tip: record the diagnosis as "stage 2 hypertension, uncontrolled, asymptomatic, no known hypertensive emergency," with diabetes as a comorbidity and high cardiovascular risk. Add "chronic" only if he already has a known diagnosis or has been on treatment.
I did not search for new studies this time, and I can't see his full history. Any change should be made by the treating clinician using his age, kidney function, current medications and local guidelines. If you share those, I can suggest specific drugs and doses.
This is a shared conversation. Sign in to Orris to start your own chat.